Oliver Weigert
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 50
- Oncology 38
- Viral-associated cancers and disorders 18
- CAR-T cell therapy research 9
- Co-authors
- Wolfgang Hiddemann (37 shared papers)David M. Weinstock (20 shared papers)Martin Dreyling (27 shared papers)Michael Unterhalt (20 shared papers)Vindi Jurinović (9 shared papers)Ross L. Levine (1 shared paper)Chao Lü (1 shared paper)Justin R. Cross (1 shared paper)
- Journals
- Blood (37 papers)British Journal of Haematology (2 papers)Blood Advances (2 papers)Journal of Clinical Oncology (2 papers)Clinical & Translational Oncology (1 paper)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Oliver Weigert
70 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 68
- Pathology and Forensic Medicine 788
- Genetics 403
- Oncology 657
- Hematology 157
- Reproductive Medicine 107
Countries citing papers authored by Oliver Weigert
This map shows the geographic impact of Oliver Weigert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Weigert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Weigert more than expected).
Fields of papers citing papers by Oliver Weigert
This network shows the impact of papers produced by Oliver Weigert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Weigert. The network helps show where Oliver Weigert may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Weigert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 150 | |
| 2 | 2016 | 137 | |
| 3 | 2011 | 64 | |
| 4 | 2018 | 61 | |
| 5 | 2005 | 60 | |
| 6 | 2007 | 47 | |
| 7 | 2012 | 45 | |
| 8 | 2018 | 42 | |
| 9 | 2021 | 41 | |
| 10 | 2009 | 40 | |
| 11 | 2016 | 40 | |
| 12 | 2018 | 39 | |
| 13 | 2019 | 36 | |
| 14 | 2012 | 34 | |
| 15 | 2016 | 30 | |
| 16 | 2016 | 29 | |
| 17 | 2012 | 28 | |
| 18 | 2021 | 28 | |
| 19 | 2012 | 26 | |
| 20 | 2017 | 24 |
About Oliver Weigert
Oliver Weigert is a scholar working on Pathology and Forensic Medicine, Oncology, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 74 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (50 papers), Chronic Lymphocytic Leukemia Research (20 papers), Viral-associated cancers and disorders (18 papers), CAR-T cell therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Ubiquitin and proteasome pathways (7 papers), Immune Cell Function and Interaction (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (788 citations), Genetics (403 citations), Oncology (657 citations), Hematology (157 citations) and Reproductive Medicine (107 citations). Oliver Weigert has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Wolfgang Hiddemann, David M. Weinstock, Martin Dreyling, Michael Unterhalt, Vindi Jurinović, Ross L. Levine, Chao Lü, Justin R. Cross, Patrick S. Ward and Craig B. Thompson. Their work appears in journals such as Blood, British Journal of Haematology, Blood Advances, Journal of Clinical Oncology and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.